Evidence map›Paper›PMID 24334183›Full record

Trial reportHIV clinical trials

Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications.

W Todd Cade, Dominic N Reeds, E Turner Overton, Pilar Herrero, Alan D Waggoner, Erin Laciny, Coco Bopp, Sherry Lassa-Claxton, Robert J Gropler, Linda R Peterson and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in HIV clinical trials. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Cardiovascular disease associated with the human immunodeficiency virus: an update.Current treatment options in cardiovascular medicine · 2014
    Article
  5. Preventing Heart Failure in Inflammatory and Immune Disorders.Current cardiovascular risk reports · 2014
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

W Todd CadeProgram in Physical Therapy, Washington University School of Medicine, St. Louis, Missouri.
Dominic N ReedsDivision of Geriatrics and Nutritional Science, Washington University School of Medicine, St. Louis, Missouri.
E Turner OvertonDivision of Infectious Disease, Washington University School of Medicine, St. Louis, Missouri.
Pilar HerreroDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Alan D WaggonerCardiovascular Division, Washington University School of Medicine, St. Louis, Missouri.
Erin LacinyDivision of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine, St. Louis, Missouri.
Coco BoppDivision of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine, St. Louis, Missouri.
Sherry Lassa-ClaxtonDivision of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine, St. Louis, Missouri.
Robert J GroplerDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Linda R PetersonCardiovascular Division, Washington University School of Medicine, St. Louis, Missouri.
Kevin E YarasheskiDivision of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine, St. Louis, Missouri.

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNITU01AI069495 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2007 to 2011
$7.7M
Myocardial Function /FFA Metabolism in HIV Metabolic SynR01DK059531 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2000 to 2008
$3.8M
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNITUM1AI069495 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 2012 to 2013
$2.9M
PROTEIN TURNOVER AND ANABOLIC INTERVENTIONS IN AIDSR01DK049393 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 1994 to 2008
$2.2M
Yoga for the Management of HIV-Metabolic SyndromesR21AT003083 · NCCIH · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2005 to 2007
$604k
NCATS NIH HHS UL1 TR000448NCCIH NIH HHS AT003083NCCIH NIH HHS R21 AT003083NCRR NIH HHS K23 RR019508NCRR NIH HHS M01 RR000036NCRR NIH HHS P41 RR000954NCRR NIH HHS RR000954NCRR NIH HHS RR019508NCRR NIH HHS RR024992NCRR NIH HHS UL1 RR024992NIAID NIH HHS AI069495NIAID NIH HHS U01 AI069495NIAID NIH HHS UM1 AI069495NIDDK NIH HHS DK020579NIDDK NIH HHS DK049393NIDDK NIH HHS DK056341NIDDK NIH HHS DK059531NIDDK NIH HHS DK074343NIDDK NIH HHS K01 DK074343NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30DK056341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS R01 DK049393NIDDK NIH HHS R01 DK059531NIDDK NIH HHS R56 DK049393
6 · The paper itself

Abstract

backgroundIndividuals with HIV infection and peripheral metabolic complications have impaired basal myocardial insulin sensitivity that is related to left ventricular (LV) diastolic dysfunction. It is unknown whether interventions shown to be effective in improving peripheral insulin sensitivity can improve basal myocardial insulin sensitivity and diastolic function in people with HIV and peripheral metabolic complications.

objectiveIn a pilot study, we evaluated whether the peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist pioglitazone or combined endurance and resistance exercise training improves basal myocardial insulin sensitivity and diastolic function in HIV+ adults with peripheral metabolic complications.

designTwenty-four HIV+ adults with metabolic complications including peripheral insulin resistance were randomly assigned to 4 months of pioglitazone (PIO; 30 mg/d) or supervised, progressive endurance and resistance exercise training (EXS; 90-120 min/d, 3 d/wk). Basal myocardial substrate metabolism was quantified by radioisotope tracer methodology and positron emission tomography (PET) imaging, and LV function was measured by echocardiography.

resultsTwenty participants completed the study. Neither PIO nor EXS resulted in a detectable improvement in basal myocardial insulin sensitivity or diastolic function. Post hoc analyses revealed sample sizes of more than 100 participants are needed to detect significant effects of these interventions on basal myocardial insulin sensitivity and function.

conclusionsPIO or EXS alone did not significantly increase basal myocardial insulin sensitivity or LV diastolic function in HIV+ individuals with peripheral metabolic complications.

Indexed as

ExerciseAdultFemaleHIV InfectionsHumansHypoglycemic AgentsInsulin ResistanceMaleMyocardiumPilot ProjectsPioglitazoneProspective StudiesThiazolidinedionesVentricular Function, LeftHypoglycemic AgentsPioglitazoneThiazolidinedionesexerciseHIVinsulin resistanceleft ventricular dysfunctionmetabolic syndrome

Identifiers

PMID24334183
PMCPMC3934557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.